These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10658974)

  • 1. NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals.
    Bakker AB; Wu J; Phillips JH; Lanier LL
    Hum Immunol; 2000 Jan; 61(1):18-27. PubMed ID: 10658974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of DAP12 with activating CD94/NKG2C NK cell receptors.
    Lanier LL; Corliss B; Wu J; Phillips JH
    Immunity; 1998 Jun; 8(6):693-701. PubMed ID: 9655483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell signaling pathways.
    Vivier E; Nunès JA; Vély F
    Science; 2004 Nov; 306(5701):1517-9. PubMed ID: 15567854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).
    Long EO; Barber DF; Burshtyn DN; Faure M; Peterson M; Rajagopalan S; Renard V; Sandusky M; Stebbins CC; Wagtmann N; Watzl C
    Immunol Rev; 2001 Jun; 181():223-33. PubMed ID: 11513144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice.
    Furukawa H; Iizuka K; Poursine-Laurent J; Shastri N; Yokoyama WM
    J Immunol; 2002 Jul; 169(1):126-36. PubMed ID: 12077237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paired inhibitory and triggering NK cell receptors for HLA class I molecules.
    López-Botet M; Bellón T; Llano M; Navarro F; García P; de Miguel M
    Hum Immunol; 2000 Jan; 61(1):7-17. PubMed ID: 10658973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands.
    Naper C; Hayashi S; Kveberg L; Niemi EC; Lanier LL; Vaage JT; Ryan JC
    J Immunol; 2002 Jul; 169(1):22-30. PubMed ID: 12077224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant.
    Lin Chua H; Brahmi Z
    Cell Immunol; 2002 Sep; 219(1):57-70. PubMed ID: 12473268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
    Lowin-Kropf B; Kunz B; Schneider P; Held W
    Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells.
    Vaidya SV; Mathew PA
    Immunol Lett; 2006 Jun; 105(2):180-4. PubMed ID: 16621032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.
    Lanier LL; Corliss BC; Wu J; Leong C; Phillips JH
    Nature; 1998 Feb; 391(6668):703-7. PubMed ID: 9490415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
    Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D
    J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
    McVicar DW; Burshtyn DN
    Sci STKE; 2001 Mar; 2001(75):re1. PubMed ID: 11752646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human NK cells and their receptors.
    Moretta L; Biassoni R; Bottino C; Cantoni C; Pende D; Mingari MC; Moretta A
    Microbes Infect; 2002 Dec; 4(15):1539-44. PubMed ID: 12505526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells.
    Joncker NT; Raulet DH
    Immunol Rev; 2008 Aug; 224():85-97. PubMed ID: 18759922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.